Cell therapy involves the transplantation of viable cells into a patient in order to trigger a medicinal effect. CAR-T is a popular form of cell therapy, specifically immunotherapy, that can use a patient’s own altered immune cells to fight cancer.

In this podcast, Annalisa Ruggeri, MD, of IRCCS OSpedale Pediatrico Bambino Gesu, Noopur Raje, MD, of Massachusetts General Hospital, Matthew Frigault, MD, of Massachusetts General Hospital, and Maksim Mamonkin, PhD, of Baylor College of Medicine discuss key updates and clinical trial results in the field of CAR-T and cellular therapies presented at EBMT 2020.

The post Advances in CAR-T and cellular therapy from EBMT 2020: MSCs, clinical trial updates and gene-edited effector cells appeared first on VJHemOnc.